It is a chemicals and materials public limited company based in Mumbai, Maharashtra, India, established in 1998.
1998 | Mumbai, Maharashtra, India | ActiveGlobex Laboratories (R&D) Limited, a active public limited company, was established on 29 June 1998 in Mumbai, Maharashtra, India. Engaging in dyes & pigments within the manufacturing sector, it holds CIN: U24150MH1998PLC115539. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹15.00 Cr and a paid-up capital of ₹8.91 Cr.
Formerly known as Globex Laboratories (R&D) Private Limited, Rex-Tone Organic Industries Private Limited. It upholds a compliant status. Employing 29 professional, Its leadership includes Shakun Harish Goswamy (Managing Director), Neerav Harish Goswamy (Director), Harish Chunilal Goswamy (Director). Past directors included Shakun Harish Goswamy, Saurabh Harish Goswamy. It holds ₹8.00 Cr open charges and ₹31.90 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 16, Yashodham Shopping Center, Film City Road, Goregaon (East), Mumbai, Maharashtra, 400063.
U24150MH1998PLC115539
115539
29 June 1998
₹15.00 Cr
₹8.91 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Globex Laboratories (R&D) Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shakun Harish Goswamy | Managing Director | 29 Jun 1998 | Current |
| Neerav Harish Goswamy | Director | 29 Jun 1998 | Current |
| Harish Chunilal Goswamy | Director | 29 Jun 1998 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Jan 2009 | Past |
| Pramod Abcsdd | Director | 23 Jun 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Globex Laboratories (R&D) Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2023, Globex Laboratories (R&D) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹80,000,000.00
₹319,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Dec 2020 | Others | ₹8.00 Cr | Open |
| 24 Dec 2020 | Others | ₹5.00 M | Satisfied |
| 06 Oct 2015 | Others | ₹9.00 Cr | Satisfied |
| 18 Apr 2013 | Tata Capital Financial Services Limited | ₹13.00 Cr | Satisfied |
| 11 Jan 2012 | Others | ₹9.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Globex Laboratories (R&D) has a workforce of 29 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Globex Laboratories (R&D), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Globex Laboratories (R&D)'s trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Globex Laboratories (R&D) Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.
Progress on Globex Laboratories (R&D) Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was documented.
A charge registered on 24 Dec 2020 via Charge ID 100396820 with Others was fully satisfied on 12 Mar 2024. was recorded as a recent event.
A charge with Others of Rs. 0.50 Cr registered on 24 Dec 2020 with Charge ID 100396820 was modified on 12 Mar 2021. was recorded as a recent event.
A charge with Others of Rs. 8.00 Cr registered on 23 Dec 2020 with Charge ID 100396821 was modified on 12 Mar 2021. was recorded as a recent event.
The activity A charge registered on 06 Oct 2015 via Charge ID 10595894 with Others was fully satisfied on 18 Feb 2021. was completed.
The CIN of Globex Laboratories (R&D) Limited is U24150MH1998PLC115539.
Globex Laboratories (R&D) Limited is headquartered at 16, Yashodham Shopping Center, Film City Road, Goregaon (East), Mumbai, Maharashtra, 400063.
Globex Laboratories (R&D) Limited was incorporated on 29 June 1998.
The current directors of Globex Laboratories (R&D) Limited are
The primary industry of Globex Laboratories (R&D) Limited is Manufacturing.
Globex Laboratories (R&D) Limited is unlisted.
The authorized capital of Globex Laboratories (R&D) Limited is ₹15.00 Cr, and the paid-up capital is ₹8.91 Cr.
The compliance status of Globex Laboratories (R&D) Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX